Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders Transcript

Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel

The approval by the USFDA is for the abbreviated new drug application (ANDA) of Dapsone gel, 5 per cent

Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug

Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Form 8K Ligand Pharmaceuticals Incorporated For: 22 June

Form 8K Ligand Pharmaceuticals Incorporated For: 22 June

Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript

Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript

New drug offers hope to MND patients

A drug developed in Queensland offers a breakthrough in the treatment of MND.

Canada approves 1st generic semaglutide shot for weight loss

It's the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.

Africa: 'One Injection Protects Up to Six Months' - What Is New HIV Drug Lenacapavir?

[RFI] As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about how the treatment works, whether the supply will meet demand and why developing an HIV vaccine remains a challenge.

FDA Expands Moringa Salmonella Outbreak Warning as Recall Grows to 119 Cases Across 36 States

FDA updated the moringa Salmonella outbreak June 30, 2026. 119 ill in 36 states, 32 hospitalized. Recall now covers TNVitamins, Live it Up, Doctor's Pride, Why Not Natural.

FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%

The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.

Orforglipron is a new drug that has proven more effective for weight loss and blood sugar control than injectible semaglutides. Bonus: comes in a daily pill, is cheaper to produce, and the name automatically invokes Rule 34 [Interesting]

[link] [24 comments]

Experimental vaccine shows promise against dangerous intestinal illness

New ETEC vaccine technology targeting enterotoxigenic Escherichia coli has been licensed to Valneva after decades of research at University of Bergen.

AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash

AbbVie has agreed to buy Apogee Therapeutics for about 10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.

Global RSV vaccine study finds maternal instinct prevails: Women worldwide reject risky newborn vaccination

(NaturalNews) The pharmaceutical industry has spent billions developing a monoclonal antibody injection for newborns called nirsevimab, yet a sweeping international...

Urgent recall issued for 685,000 bags of popular crisps

Salmonella is an organism that can cause serious and sometimes fatal illness

New weight loss pill beats oral Ozempic in major trial

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.

Vertex Pharmaceuticals is buying Crinetics to expand into rare hormonal diseases

The deal gives Vertex access to Palsonify, an oral acromegaly treatment, and atumelnant, a late-stage drug for congenital adrenal hyperplasia

I've had a UTI every few months for five years - and antibiotics don't work: Don't worry, says DR ELLIE. Here's how to beat them for good - and the hidden cause no one realises is to blame

I've had a UTI every few months for five years - and antibiotics don't work: Don't worry, says DR ELLIE. Here's how to beat them for good - and the hidden cause no one realises is to blame